Status:
NOT_YET_RECRUITING
ctDNA and MRI Parameters in Head and Neck Cancer
Lead Sponsor:
Franziska Eckert
Conditions:
Head and Neck Neoplasms
Carcinoma, Squamous
Eligibility:
All Genders
19-100 years
Phase:
NA
Brief Summary
Patients undergoing primary radiochhemotherapy for locally advanced head and neck squamous cell carcinomas are included in this study. In addition to standard of care treatment patients will undergo a...
Eligibility Criteria
Inclusion
- Squamous cell carcinoma head and neck
- Planned primary platinum based radiochemotherapy
- ECOG 0-2
Exclusion
- Palliative therapy intent
- Not MR eligible
Key Trial Info
Start Date :
February 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2030
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06215612
Start Date
February 1 2024
End Date
February 1 2030
Last Update
January 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.